National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia; School of Psychological Sciences, University of Tasmania, Hobart, Australia.
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Int J Drug Policy. 2021 Nov;97:103334. doi: 10.1016/j.drugpo.2021.103334. Epub 2021 Jul 7.
Colorimetric reagent kits can provide information about the compounds present in drug samples. This study aimed to identify patterns and correlates of colorimetric reagent kit use, as well as behavioural outcomes of testing, amongst people who use illegal stimulants in a context that lacks permanent government-sanctioned drug checking services.
Australians residing in capital cities who reported regularly using ecstasy/MDMA and/or other illegal stimulants ≥monthly in the past six months were recruited via social media and word-of-mouth from April-July 2019 (N = 792). Participants were asked about testing the contents and/or purity of illegal drugs, and features of last colorimetric reagent kit use. Logistic regression identified correlates of last using a kit (referent: no use of drug checking technology to test drug contents/purity in the past year).
Over one-third (36%) reported testing drug contents and/or purity; of this group, 86% had last used a colorimetric reagent kit. On the last occasion, 52% reported someone else had conducted testing; 58% said testing occurred <24 h before planned drug use; and 24% reported testing for quantity of a substance. Correlates of drug checking comprised: being younger, male, past six-month use of new psychoactive substances, accessing community-based health services for alcohol or other drug reasons, selling drugs for cash profit, obtaining information from peers who had tried the drug, and searching online for reports of the drug by stamp/appearance. The majority (84%) tested a substance they had been sold and/or given as MDMA; of these, 87% detected MDMA. Of those who expected and detected MDMA, 29% and 11% reported results to their peers and dealer, respectively.
People who use ecstasy/MDMA and/or other illegal stimulants seek out objective information about substance contents. In countries that lack permanent government-sanctioned drug checking services, it is important to acknowledge that people already engage in drug checking but with suboptimal technologies and without tailored specialist advice and education.
比色试剂试剂盒可以提供有关药物样品中存在的化合物的信息。本研究旨在确定在缺乏永久性政府批准的药物检测服务的环境中使用非法兴奋剂的人群中,比色试剂试剂盒使用的模式和相关性,以及测试的行为结果。
2019 年 4 月至 7 月,通过社交媒体和口碑从居住在首府城市、报告过去六个月每月至少使用一次摇头丸/MDMA 和/或其他非法兴奋剂的澳大利亚人中招募了报告经常使用摇头丸/MDMA 和/或其他非法兴奋剂的参与者(N=792)。参与者被问及测试非法药物的含量和/或纯度,以及最后一次使用比色试剂试剂盒的情况。逻辑回归确定了最后一次使用试剂盒的相关性(参考:过去一年没有使用药物检测技术测试药物含量/纯度)。
超过三分之一(36%)的人报告测试药物含量和/或纯度;在这一组中,86%的人最后一次使用比色试剂试剂盒。在上一次测试中,52%的人报告有人进行了测试;58%的人表示测试发生在计划使用药物前<24 小时;24%的人报告测试物质的数量。药物检测的相关性包括:年龄较小、男性、过去六个月使用新精神活性物质、因酒精或其他药物原因寻求社区卫生服务、为现金利润出售毒品、从尝试过该药物的同伴那里获取信息,以及在线搜索该药物的报告。大多数人(84%)测试了他们被出售和/或给予的作为 MDMA 的物质;其中 87%的人检测到 MDMA。在那些期望并检测到 MDMA 的人中,29%和 11%的人分别向他们的同伴和经销商报告了结果。
使用摇头丸/MDMA 和/或其他非法兴奋剂的人会寻求有关物质含量的客观信息。在缺乏永久性政府批准的药物检测服务的国家,重要的是要承认人们已经在进行药物检测,但使用的技术不够理想,并且没有量身定制的专业建议和教育。